A prospective, observational study of rivaroxaban for stroke prevention in atrial fibrillation: the XANAP Korea
Jaemin Shim, Young Keun On, Sun U. Kwon, Gi-Byoung Nam, Moon-Hyoung Lee, Hyung-Wook Park, Keun-Sik Hong, Nam-Ho Kim, Pierre Amarenco, Seung-Woon Rha, Dong-Gu Shin, Joung-Ho Rha, Young-Hoon Kim
Korean J Intern Med. 2021;36(4):906-913. Published online 2021 Jun 11 DOI: https://doi.org/10.3904/kjim.2020.217
Citations to this article as recorded by 
Efficacy and safety of rivaroxaban in prevention and therapy of thromboembolic events in patients with nonvalvular atrial fibrillation
TamaraKovačević Preradovic, Siniša Miljković, Ljiljana Kos, Aziz Šukalo, Una Glamočlija, AmnaTanović Avdić, Meliha Mehić
Journal of the Practice of Cardiovascular Sciences.2023; 9(2): 110. CrossRef
Rivaroxaban: striking two birds with one stone
Yae Min Park
The Korean Journal of Internal Medicine.2021; 36(4): 842. CrossRef